Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Prashant Kesharwani

Showing results (1-10 of 488) with videos related to

Pageof 49
Sort By:
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 8, 2021
Advanced nanomedicine approaches applied for treatment of skin carcinomaHarsimran Kaur, Prashant Kesharwani
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 4, 2021
Recent advances in microneedles-based drug delivery device in the diagnosis and treatment of cancerVanshikha Singh, Prashant Kesharwani
Drug Discovery Today|February 20, 2016
Dendrimer technologies for brain tumorVijay Mishra, Prashant Kesharwani
Journal of Biomaterials Science. Polymer Edition|June 3, 2021
Dendrimer as a promising nanocarrier for the delivery of doxorubicin as an anticancer therapeuticsVanshikha Singh, Prashant Kesharwani
International Journal of Pharmaceutics|July 1, 2021
Nanotechnology-based siRNA delivery strategies for treatment of triple negative breast cancerRahul Chadar, Afsana, Prashant Kesharwani
Drug Discovery Today|January 4, 2015
Recent advances in dendrimer-based nanovectors for tumor-targeted drug and gene deliveryPrashant Kesharwani, Arun K Iyer
Microbial Pathogenesis|May 27, 2023
Contradictory perspectives on the transmission route of human monkeypox during the 2022 outbreakMasoud Keikha, Prashant Kesharwani, Amirhossein Sahebkar
AAPS Pharmscitech|April 10, 2026
Recent Advances in Surface-Engineered Polymeric Nanoparticles for Targeted Paclitaxel Delivery in Breast Cancer TherapyMahak Fatima, Fahad AlQahtani, Prashant Kesharwani
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 10, 2021
RGD engineered dendrimer nanotherapeutic as an emerging targeted approach in cancer therapyAfsana Sheikh, Shadab Md, Prashant Kesharwani
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 22, 2022
Dendrimer as a momentous tool in tissue engineering and regenerative medicineAazam Shaikh, Prashant Kesharwani, Virendra Gajbhiye
Pageof 49

Showing results (1-10 of 488) with videos related to

Sort By:
Pageof 49
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 8, 2021
Advanced nanomedicine approaches applied for treatment of skin carcinomaHarsimran Kaur, Prashant Kesharwani
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 4, 2021
Recent advances in microneedles-based drug delivery device in the diagnosis and treatment of cancerVanshikha Singh, Prashant Kesharwani
Drug Discovery Today|February 20, 2016
Dendrimer technologies for brain tumorVijay Mishra, Prashant Kesharwani
Journal of Biomaterials Science. Polymer Edition|June 3, 2021
Dendrimer as a promising nanocarrier for the delivery of doxorubicin as an anticancer therapeuticsVanshikha Singh, Prashant Kesharwani
International Journal of Pharmaceutics|July 1, 2021
Nanotechnology-based siRNA delivery strategies for treatment of triple negative breast cancerRahul Chadar, Afsana, Prashant Kesharwani
Drug Discovery Today|January 4, 2015
Recent advances in dendrimer-based nanovectors for tumor-targeted drug and gene deliveryPrashant Kesharwani, Arun K Iyer
Microbial Pathogenesis|May 27, 2023
Contradictory perspectives on the transmission route of human monkeypox during the 2022 outbreakMasoud Keikha, Prashant Kesharwani, Amirhossein Sahebkar
AAPS Pharmscitech|April 10, 2026
Recent Advances in Surface-Engineered Polymeric Nanoparticles for Targeted Paclitaxel Delivery in Breast Cancer TherapyMahak Fatima, Fahad AlQahtani, Prashant Kesharwani
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 10, 2021
RGD engineered dendrimer nanotherapeutic as an emerging targeted approach in cancer therapyAfsana Sheikh, Shadab Md, Prashant Kesharwani
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 22, 2022
Dendrimer as a momentous tool in tissue engineering and regenerative medicineAazam Shaikh, Prashant Kesharwani, Virendra Gajbhiye
Pageof 49